Navigation Links
Echo Therapeutics to Present at the Stifel Nicolaus Healthcare Conference 2011
Date:8/31/2011

PHILADELPHIA, Aug. 31, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present at the Stifel Nicolaus Healthcare Conference 2011.

Dr. Mooney will make a corporate presentation to prospective corporate partners and investors on Thursday, September 8th at 3:15PM ET.  The Company's presentation will be delivered at The Four Seasons Hotel in Boston, Massachusetts.  

At the time of the presentation, a live audio and slides webcast of Echo Therapeutics' presentation will be available at http://www.veracast.com/webcasts/stifel/healthcare2011/81212466.cfm.  Echo Therapeutics recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. The webcast and presentation will also be archived at the same web link for 30 days following the event.

About Echo Therapeutics

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

For More Information:
Christine Olimpio
Director, Corporate Communications
(215) 717-4104


'/>"/>
SOURCE Echo Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 Kewaunee Scientific Corporation (Nasdaq: ... its quarterly cash dividend by 9% to twelve cents ... beginning with the dividend payable on September 22, 2014 ... on September 8, 2014. About Kewaunee ... Scientific Corporation is a recognized global leader in the ...
(Date:8/27/2014)... NINGBO, China , Aug. 27, 2014 /PRNewswire/ ... Co., Ltd, ("Menovo") today announced they had entered into ... primarily targeting the United States ... Menovo will jointly develop products for Amerigen to commercialize ... will be responsible for manufacturing API and finished product ...
(Date:8/27/2014)... 27, 2014 Ambit Biosciences (Nasdaq: AMBI ), ... targeting unmet needs in oncology, autoimmune and inflammatory disease, today ... Conference to be held at The New York Palace Hotel ... 3-4, 2014. Alan Fuhrman , Ambit,s CFO, ... drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, September ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Ambit Announces Participation At Baird 2014 Health Care Conference 2
(Date:8/28/2014)... New York (PRWEB) August 28, 2014 An ... back and neck issues, Cloud 9 Spine offers their resources ... spine problems can quickly become a brick wall of discouragement ... for a professional opinion, Cloud 9 Spine offers ... proprietary technology merged with human interaction that sets Cloud 9 ...
(Date:8/28/2014)... Alpine, NJ resident Othon Mourkakos is proud to ... Tiaras, to benefit the Immune Deficiency Foundation (IDF) Walk ... in Foley Square, New York. IDF is the ... (PI) are a group of more than 200 rare, ... immune system is missing or functions improperly. In ...
(Date:8/28/2014)... The revenue cycle process touches on ... time a patient books an appointment with a physician’s ... payments for services rendered to the healthcare provider. ... has the RCM process down to a science. Over ... common place in nearly every healthcare facility around the ...
(Date:8/27/2014)... Asheville, NC (PRWEB) August 28, 2014 ... for companies to acquire as part of a ... business. Aeroflow is positioned for taking ownership of ... foundation to increase economies of scale. , Last ... an agreement with Hometown Respiratory to increase service ...
(Date:8/27/2014)... Spine Guide has built a reputation for itself ... health. Now, the e-health site will offer new surgical ... pain symptoms. Spine Guide specializes in three types of ... surgery. , Some of the most common back pain ... radiating down the leg, inability to stand up straight, ...
Breaking Medicine News(10 mins):Health News:Making Waves on the East Coast, Cloud 9 Spine is Helping Patients Find Appointments With Local Spine Doctors 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3Health News:Aeroflow Healthcare Seeks Strategic Acquisition Opportunities 2Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2
... Switzerland and Brussels, Belgium, 9 April 2008: The European ... European CanCer Organisation have united forces to host a ... best and most updated scientific data for everyone working ... providing all cancer patients with equal access to high-quality ...
... 2008 Ever wonder if,your doctor personally follows the ... to the recent "Life ... supplemented" Healthcare,Professionals (HCP) Impact ... behaviors, with three of the top shared healthy behaviors,being: ... regularly (73,percent) and taking vitamins and other supplements (72 ...
... Research, Programs for #1 Cause of,Fatal and Nonfatal Injuries ... A broad-based,coalition of nonprofit organizations dedicated to improving the ... of S. 845, the Safety,of Seniors (SOS) Act, clearing ... point: each year, one in three older Americans (65 ...
... counterintuitive to exercise when suffering with joint pain, but ... most people suffering from arthritis. A recent study ... regular exercise, specifically the Arthritis Foundation Exercise Program, is ... pain. This is good news for the aging ...
... April 8, 2008 The Procter &,Gamble Company (NYSE: ... in the quarterly dividend from thirty-five cents ($0.35) to forty,cents ... Series A and Series,B ESOP Convertible Class A Preferred Stock ... shareholders of record at the close of business on,April 18, ...
... Chinese studies show cancer treatment extended survival time in ... combination of the active ingredients in reishi mushrooms and ... survival time of mice with sarcomas, two Chinese studies ... fat, muscle, blood vessels, or other connective or supportive ...
Cached Medicine News:Health News:European Society for Medical Oncology and European CanCer Organization join forces 2Health News:Doctors' and Nurses' Wellness Checklist: Healthy Diet, Exercise, Dietary Supplements 2Health News:Doctors' and Nurses' Wellness Checklist: Healthy Diet, Exercise, Dietary Supplements 3Health News:Elder Falls Bill Passes Congress, Heads to President 2Health News:Elder Falls Bill Passes Congress, Heads to President 3Health News:Physical activity is natural pain reliever for arthritis 2Health News:Green Tea, Mushroom Extract Combo Slows Sarcomas 2
The High Pure Viral RNA Kit is intended for general laboratory use and is designed to purify viral RNA from serum or plasma. Viral RNA is used for RT-PCR analysis directly after elution in nuclease-f...
... This revolutionary product will provide you ... type of electroretinogram, visual evoked potential, ... ganzfeld will allow you to perform ... on-off, double flash, photopic negative response, ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... is designed for high throughput microplate processing. ... S60 Stacker that handles up to 60 ... base model is equipped with a dual ... units may be interfaced to increase flexibility ...
Medicine Products: